Stryker Corp (NYSE:SYK) Shifting Institutional Investors Sentiment

September 30, 2018 - By Pearl Odom

Stryker Corporation (NYSE:SYK) Logo

Sentiment for Stryker Corp (NYSE:SYK)

Stryker Corp (NYSE:SYK) institutional sentiment increased to 1.01 in 2018 Q2. Its up 0.25, from 0.76 in 2018Q1. The ratio improved, as 391 investment managers increased and started new positions, while 387 cut down and sold holdings in Stryker Corp. The investment managers in our partner’s database now hold: 269.24 million shares, down from 273.49 million shares in 2018Q1. Also, the number of investment managers holding Stryker Corp in their top 10 positions increased from 42 to 44 for an increase of 2. Sold All: 35 Reduced: 352 Increased: 281 New Position: 110.

Stryker Corporation, together with its subsidiaries, operates as a medical technology company. The company has market cap of $66.45 billion. It operates through three divisions: Orthopaedics; MedSurg; and Neurotechnology and Spine. It has a 62.74 P/E ratio. The Orthopaedics segment offers implants for use in hip and knee joint replacements, and trauma and extremities surgeries.

The stock increased 1.51% or $2.64 during the last trading session, reaching $177.68. About 1.37M shares traded or 20.74% up from the average. Stryker Corporation (NYSE:SYK) has risen 20.73% since September 30, 2017 and is uptrending. It has outperformed by 5.11% the S&P500.

Analysts await Stryker Corporation (NYSE:SYK) to report earnings on October, 25. They expect $1.68 earnings per share, up 10.53 % or $0.16 from last year’s $1.52 per share. SYK’s profit will be $628.31 million for 26.44 P/E if the $1.68 EPS becomes a reality. After $1.76 actual earnings per share reported by Stryker Corporation for the previous quarter, Wall Street now forecasts -4.55 % negative EPS growth.

Greenleaf Trust holds 74.18% of its portfolio in Stryker Corporation for 23.08 million shares. Bonness Enterprises Inc owns 71,000 shares or 8.48% of their US portfolio. Moreover, Gvo Asset Management Ltd has 8.25% invested in the company for 149,694 shares. The United Kingdom-based Fundsmith Llp has invested 6.93% in the stock. Dillon & Associates Inc, a Michigan-based fund reported 95,266 shares.

Since January 1, 0001, it had 1 insider buy, and 4 sales for $7.70 million activity.

Stryker Corporation (NYSE:SYK) Ratings Coverage

Ratings analysis reveals 56% of Stryker’s analysts are positive. Out of 9 Wall Street analysts rating Stryker, 5 give it “Buy”, 0 “Sell” rating, while 4 recommend “Hold”. The lowest target is $165 while the high is $192. The stock’s average target of $180.13 is 1.38% above today’s ($177.68) share price. SYK was included in 10 notes of analysts from April 3, 2018. Cantor Fitzgerald maintained the stock with “Neutral” rating in Wednesday, July 25 report. The stock of Stryker Corporation (NYSE:SYK) earned “Buy” rating by Stifel Nicolaus on Friday, April 27. The firm earned “Neutral” rating on Wednesday, July 25 by Citigroup. The firm has “Outperform” rating by Robert W. Baird given on Wednesday, July 25. The firm has “Neutral” rating by Citigroup given on Tuesday, May 1. The stock of Stryker Corporation (NYSE:SYK) has “Buy” rating given on Friday, April 27 by Canaccord Genuity.

More important recent Stryker Corporation (NYSE:SYK) news were published by: Seekingalpha.com which released: “Stryker: Aiming For 105% Return” on September 03, 2018, also Seekingalpha.com published article titled: “On Stryker’s Value”, Streetinsider.com published: “SEC Charges Stryker (SYK) A Second Time for FCPA Violations” on September 28, 2018. More interesting news about Stryker Corporation (NYSE:SYK) was released by: Seekingalpha.com and their article: “Stryker – Strikes Again In M&A” with publication date: September 02, 2018.

Stryker Corporation (NYSE:SYK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: